Shire reports analysis examining emotional lability in children with ADHD taking Vyvanse
Friday, November 13, 2009 - 10:49
in Psychology & Sociology
PHILADELPHIA -- November 12, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse®.